Brightside Health, a San Francisco, CA-based telemedicine platform that offers fast access to personalized treatment, expert providers, and ongoing support for a range of mental health concerns, raised $50m in Series B funding.
The round, which brought total funding to date to $75m, was led by ACME Capital and Mousse Partners, with participation from existing investors Bullpen Capital, Triventures, and Trousdale Ventures.
Led by Brad Kittredge, founder and CEO, Brightside Health is a telemedicine platform focused on developing and delivering a new standard of mental health care. By pairing empathy and expertise with innovative technology, the company provides a personalized treatment experience for every member through video visits, unlimited messaging, ongoing support, and medication delivery. Its care model encompasses precision-psychiatry, a clinically-proven approach to therapy, and continuous care monitoring from a network of providers.
Brightside Health treats the full spectrum of symptom severity, including people with complex conditions, and offers timely appointments from home, available in as little as 24 hours. With convenient access to treatment through video visits, unlimited messaging, ongoing support, and medication delivery, Brightside Health helps people feel better faster, and stay that way longer. The platform adheres to evidence-based approaches, guided by a world-class network of psychiatric providers and licensed therapists who utilize innovative support tools and follow structured, clinically-proven protocols to deliver effective care at scale. Members track progress through online check-ins that are also monitored by providers, ensuring the efficacy of personalized treatment plans and enabling rapid intervention should a need arise.
FinSMEs
29/03/2022